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Abstract
Considerable variation has been demonstrated in applying regulations across research ethics
committees (RECs) in the U.S., U.K., and European nations. With the rise of international
research collaborations, RECs in developing countries apply a variety of international regulations.
We conducted a qualitative descriptive pilot study with members of the national REC in Malawi to
determine criteria they use to review research, and their views on international collaborations.
Qualitative content analysis demonstrated that international guidelines are interpreted in light of
local African conditions such that emphasis is placed on examining benefit to the community and
ensuring the informed consent process translates concepts in locally-meaningful ways. Members
suggest that RECs often must comply with regulations that do not fit local conditions.
Recommendations are provided for improving such international collaborations.
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The mandate of research ethics committees (RECs) is to ensure that human subjects research
is conducted in ways that minimize risk of harm to subjects and balance risks with
anticipated benefits. Studies of such committees in the United States (U.S.), the United
Kingdom (U.K.), and Europe have documented variation in how regulations are applied and
in consistency of review across different institutions (Bell, Whiton, & Connelly, 1998;
Department of Health and Human Services [DHHS], 1998; Alberti, 1995; Alberti, 2000;
McWilliams et al., 2003; Silverman, Hull, & Sugarman, 2001; Cooper & McKee,
2001).With the rise of international research collaborations, RECs in developing countries
often apply U.S., U.K., European, or other international regulations. These RECs face
additional challenges posed by limited resources, poorly defined lines of authority between
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RECs and external parties including investigators and other RECs, and the proliferation of
new types and increasing numbers of research protocols.
At the same time, clinical research conducted in developing countries has also produced a
number of controversies related to justice, standard of care, and sustainability. These have
been raised in commentaries from developed (e.g., Angell, 1988) and developing nations
(e.g., Del Rio, 1998; Bhutta, 2002; Benatar, 2000) and have been influential in the revision
of international guidelines. For example, the Declaration of Helsinki revision in 2000 and
Council for International Organizations of Medical Sciences (CIOMS) revision in 2002 were
aimed in large part to address issues such as placebo-controlled trials and post-study access
in developing regions. Not all revisions harmonized, however, as in the case with revisions
to the Declaration that rule out research with healthy children or those incapable of giving
consent, creating contradictions with CIOMS and U.S. guidelines. While dilemmas in
international research ethics have been raised in the bioethics literatures (e.g., Macklin,
1999; National Bioethics Advisory Commission, 2001; Benatar, 2004), there have been few
reports on the views of local RECs. For this reason, we initiated a qualitative, descriptive
pilot study of members of one such REC in Malawi, in 2004, in order to understand their
perspectives on how well international collaborations work and what they look for when
they review such protocols.
Methods
In June 2004, in-depth interviews were conducted with 11 of 14 members of the Malawi
National Health Sciences Research Committee (NHSRC). Three members were either out of
the country or could not be reached for the interviews. The NHSRC is the national REC in
Malawi associated with the Ministry of Health; a second REC was established at the College
of Medicine in the late 1990s and shares many members with the NHSRC.
The purpose of the interviews was to determine the criteria used by the committee to review
research protocols, to better understand the challenges they face, to gain knowledge of their
perceptions of international collaborations, and to explore how to build successful
relationships with research ethics committees in the United States and elsewhere. Topics
included specific questions about the review process, including how they assessed informed
consent, risk, benefit, and vulnerable populations; the role of the ethics committee and
relationships with other committees; potential influences on independent review; and overall
assessments and training needs. A separate questionnaire was used with the REC Chair.
Interviews were conducted by an American medical student in English and each lasted
between 1 and 1.5 hours. Each interview was audio-taped and transcribed word-for-word.
Because of the pilot nature of this research, we chose to use an in-depth interviewing
approach, with an interview guide that did not require questions be asked verbatim or in
identical order in each interview. Qualitative content analysis was used to analyze the data.
Three authors reviewed all transcripts to understand each REC member’s individual
perspective on the interview topics, and the lead author identified broad deductive codes
based on study objectives. Working independently, each transcript was coded by two
authors and then reviewed in a group to identify and discuss the main themes that emerged
within each broad code. Quotes were identified within each code as representative of the
perspectives of several REC members. Results presented here are a summary of the main
areas discussed within these codes and were confirmed by follow-up discussions with the
REC members. The research was approved by the Malawi NHSRC and the Institutional
Review Board at the University of North Carolina at Chapel Hill. All participants gave their
verbal informed consent.
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THE HISTORY, DEMOGRAPHICS, AND REVIEW ACTIVITIES OF THE REC
Established in 1988, this REC, referred to as the National Health Science Research
Committee, falls under the supervision of the National Research Council of Malawi but is
housed in the Ministry of Health. At the time of the interviews, the REC had 14 regular and
four alternate members, including four medical doctors, four with other doctorate degrees,
five with masters degrees, and five with bachelor degrees. Four members were women; non-
scientific members included an ethicist and a sociologist. The REC met every three months
(currently every two months) and reviewed 40–50 new protocols annually. Of these, 10 to
15 each year were judged by the Chair to involve no more than minimal risk and given
expedited review.
Approximately half of the protocols reviewed by the REC were international collaborations.
Most originated in the U.S. or U.K., were on HIV/AIDS or malaria, were directly funded by
the National Institutes of Health, U.K. universities, Wellcome Trust, or the Global Fund to
Fight AIDS, Tuberculosis, and Malaria. The REC relied upon ethical guidelines put forth by
the WHO (World Health Organization [WHO], 2000), although they also consulted
guidelines from the U.S. DHHS, CIOMS, and the Declaration of Helsinki.
INFORMED CONSENT
REC members agreed with the principle of voluntary, informed consent; however, they
expressed doubt about the effectiveness of the current informed consent process used by
researchers. As summarized by one REC member [Participant #5]: “We agree with the
principle of informed consent … and that people have to understand, but in fact this is not
happening. So the question is should we stick to the things that are not working? We should
not have lower standards, but your principles are not working on the ground.” Members’
concerns focused primarily on the belief that potential study participants typically do not
fully understand information presented to them during the consent process. Inadequate time
given to participants to explain the research was identified as a cause of limited
understanding. An REC member explained: “The problem is that very little [time] is spent
explaining to people what the study is all about. … More time must be spent for the subjects
to know … why it is being conducted, what you want to achieve at the end of the day, and
then we need to make sure the subjects understand what the study is all about.” [Participant
#7] Members believed, however, that participants would be able to understand consent
information if adequate time for discussion was provided. One member said: “If you give it
time according to the literacy level of the subject, then I think it is possible [for the
respondent to understand consent information]” [Participant #2].
REC members also stressed that participants’ low literacy and difficulty with understanding
long scientific explanations must be addressed. Consent forms must be written in language
“using the simplest terms possible so that the subjects can understand.” [Participant #2]
They emphasized not only the importance of translating the consent forms into the local
language, but the need for transferring the meaning of concepts: “The consent form has to
be translated into the local language so that people can understand … and it is not just a
question of translation, but it has to carry the meaning in the original version.” [Participant
#8]
Another reason cited for limited understanding was the length of the consent forms. Several
REC members questioned why American RECs approved such long consent forms when it
is clear they are difficult for participants to understand, suggesting that the consent forms
serve as legal documents to protect researchers: “Researchers are not going to read a 30-
page consent form to the subject … You have made it a legal document and nothing more.”
Henderson et al. Page 3













[Participant #6] Members stressed that forms must be short and precise. Moreover, as stated
by one REC member: “A long informed consent is defeating the whole objective … Too
much information is not understandable.” [Participant #5] Another member said: “We
believe that the longer the consent form, the possibility of the subject to lose concentration
[increases.]” [Participant #8]
Consistent with findings from other studies (Kass, Sugarman, Faden, Schoch-Spana, &
Trust, 1996), REC members noted that some participants agree to participate in research
simply because they trust researchers, whom they believe will do their best for them or their
child. Thus, the REC looks for statements in consent forms that stress voluntariness. As
stated by one REC member: “[Are researchers] asking [for participation] versus demanding
… Are they giving the individual a choice?” [Participant #2]
VULNERABLE POPULATIONS
Several observed that autonomy must be understood in the Malawian context, that is, “[in
Malawi] you can talk about autonomous communities and autonomous groups, but not
autonomous individuals. It doesn’t mean that people do not make personal decisions …
there is a need for individual autonomy for personal identity, [but] here autonomy is
relational.” [Participant #5] The influence of local leaders over these decision-making
processes has moderated in recent years. Village chiefs still must be informed of impending
research in their community, but “… people know they have rights now. The chief might say
yes, [yet one should not] take it for granted that everybody shall say yes.” [Participant #7]
REC members perceived study subjects in the U.S. and U.K. to be more independent in their
decision-making, yet one member observed: “I don’t know how truly autonomous a poor
person is in America. Autonomy suggests that you have alternatives … A lot of the
difference between the West and Africa does not have to do with what we’re discussing
[autonomy]. It has to do with being rich and poor.” [Participant #6] Poverty was cited by
almost everyone as a sign of vulnerability, and “… virtually every person enrolled in studies
in Malawi is poor.” [Participant #6] As well, limited education was mentioned, and a few
respondents identified gender as a source of vulnerability because of its link to poverty and
low literacy.
RISKS
With so many studies of HIV and other infectious diseases, almost all REC members
mentioned stigma as a primary risk of research participation. For example: “When [study
staff go to a participant’s house] to draw blood to test for HIV, what will the community talk
about? They will say this person has HIV … so we look at such risks.” [Participant #4] As a
result, REC members explained that they spend significant time examining risks beyond the
potential physical risks and evaluate the potential for research procedures to identify and
stigmatize participants. As explained by one member: “We look at social risks such as risks
to privacy and confidentiality. Social risk can become a physical risk, for example, if a wife
participates in HIV/AIDS research and is identified as having HIV, she could be harmed by
her husband.” [Participant #5] Another member [Participant #6] discussed the social and
ethical implications of a vaccine trial, such that outside the study setting, participants may
not be able to differentiate new infection from vaccine-related seropositivity. In addition,
this member explained: “[the implications of testing HIV positive] was discussed at length
when reviewing vaccine protocols … We were more concerned about social-psychological
issues almost than we were about the physical risks.” REC members also understood that
minimizing stigma was also “clearly in the researcher’s best interest because if you
stigmatize people, they won’t come or they won’t return.” [Participant #6]
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When assessing benefit, one member summarized the committee’s views by stating: “…
first we look at the benefits to the community.” [Participant #8] Every REC member
emphasized that they examine the benefit to the community in particular and focus less on
individual benefits, and in the review process they look “to see if the investigator has put
any effort to inform the subject what the benefits are for the individual and for the society.”
[Participant #1] Examples of community benefits included addressing underlying health
problems, bringing in new medications, or creating infrastructure, noting that the committee
pays attention to whether projects will ‘build capacity.’ This concern was linked specifically
to the experiences with HIV research, which “brought [the issue] to the forefront. In
developing countries, where you’re left high and dry once the study finishes, it’s always an
ethical dilemma.” [Participant #6]
It was important to clarify that research might not benefit individual participants. One
member explained: “… I think it’s too narrow of a view to suppose that every research
project undertaken will be of benefit to the individual. I think there is a real view that the
community needs to feel happy that even though they don’t benefit now, they may benefit in
the future. It’s important to make people aware of that. If we insisted on those particular
benefits [to the individual], you would never get any basic research done at all.” [Participant
#6] Another member articulated a hierarchy of benefits: “First of all we look at the benefits
to the community, and not to the individuals. And also we look at how the study is going to
benefit the institution doing the study … Finally, we can look at the benefits to the
individuals.” [Participant #8] While members recognized that community benefit, such as
construction of a hospital, can also benefit the individual, one member said: “… usually we
discourage [discussing] individual benefits because it is like coercing people into the study.”
[Participant #4]
The Role of REC in International Collaborations: Barrier or Facilitator?—REC
members believed that local and international researchers have “mixed views” about their
committee and its role. When asked how they believe international investigators perceive
their REC, many said they were seen as “police officers,” blocking research and delaying
scientific progress. They feel pressure from such statements by international collaborators
as, “This study was already approved by our country, why are you taking so long?” and said
that investigators who think that they will have “an easy ride … are shocked” [Participant
#5] when the REC does not automatically approve their studies. One member stated that
researchers in Malawi have “more responsibility than in the U.S. to make sure that they
maintain the public trust,” [Participant #6] and several REC members expressed concern
about protecting the country’s ownership rights to research results. For example, one
member said: “The government should be aware of whatever you want to publish or do with
the data. After all, you are doing the study to solve problems which are affecting the people
in Malawi.” [e.g., study data collected in Malawi is property of the Malawi government.]
[Participant #9]
Conversely, members felt that many international investigators appreciate the REC’s
contributions to the ethical conduct of research. This can take the form of logistical help in
study design and execution, but is most commonly described as making the research
“culturally feasible.” This role of culture broker was identified in several interviews. It was
suggested that local investigators are a key component since, “if you don’t have local
investigators, then you don’t have insight into what is culturally acceptable.” [Participant
#6] As an example, several members mentioned misunderstandings when researchers
proposed to draw blood, causing fear that they would sell it or “play magic” with it. In
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response, the REC strongly counsels researchers to engage in community education prior to
recruitment.
The interviews also revealed a tension between balancing the promotion of the research and
the protection of the study participants. As described by one member: “When we review
protocols, we make sure that human subjects are protected; that is number one. We make
sure that research is done accordingly and we make sure that human subjects are protected.”
[Participant #10] On the other hand, one member called attention to difficulties experienced
by researchers when they submit protocols for review: “I feel … human [subjects] are
protected by giving the right information … I am afraid [however] that we can see the
researcher being [disadvantaged], in fact … because we concentrate very much on the
research participant, we have seen that [RECs] are very strict on simple things to the point of
actually hindering research.” [Participant #5]
Lastly, members were concerned that no formal or informal mechanisms for communication
existed between international RECs and the Malawi REC. Members expect international
collaborators submitting protocols to have them reviewed by their own REC first, but they
also believe that the final decision is theirs: “Clearly people are influenced by what other
RECs have said, but the final say is with us.” [Participant #6]
Discussion
A qualitative descriptive study with members of only one REC has limited generalizability,
particularly in light of documented variation in history, demographic characteristics, and
review procedures among African RECs (Kass et al, 2007; Kirigia, J.M., Wambebe, C., &
Baba-Mousa, A., 2005; see also Sugarman, J., Popkin, B., Fortney, J, & Rivera, R., 2001).
In their report of 12 African RECs, ranging from several that were established recently to
one founded in 1967, Kass and colleagues (2007) concluded that committees become more
stable, equipped, and trained over time. In comparison to the RECs described in their report,
the Malawi NHSRC is average in terms of number of members, protocols reviewed,
proportion of international vs. domestic protocols, and identification of strengths and
challenges. Descriptions of difficulties with informed consent forms and requirements from
external sponsors or investigators are similar to those reported by Sugarman and colleagues
(2001) based on data gathered during focused site visits in eight countries.
In this pilot study, we found that various international research ethics guidelines are
interpreted by this REC in light of local African conditions, such that emphasis is placed on
examining benefit to the community and ensuring that the informed consent process
translates concepts in locally meaningful ways. International investigators are advised about
how to proceed in culturally appropriate ways and to collaborate actively with local
investigators. While not surprising, these findings provide empirical evidence that normative
guidance at the national and international level is being implemented by an REC in this
African setting. In addition, the interviews did not reveal close attention to a particular
international guideline or to differentiating between U.S., U.K., and European guidelines,
but rather, as is typical in the U.S. as well, the REC members discussed how they applied
general principles rather than specific regulations.
This REC demonstrated considerable sophistication as members review protocols and
balance competing interests. While protection of human research subjects is defined in the
regulations as their primary objective, RECs take various stances vis-à-vis the research
enterprise, some collaborative, some more adversarial. In this way, they resemble RECs in
the West (Nelson, 2006b). However, differences were observed with respect to how
“benefits” are defined and to the REC role as culture broker vis-à-vis external investigators.
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The REC members’ greatest concern is the inadequacy of a legalistic consent process that is
not responsive to the needs of local study participants. Echoed by Bhutta (2004), the process
of obtaining informed consent for research in developing countries is often unclear, and
focuses on written documentation and emphasis on literal translations of consent forms. The
complexity and length of consent forms, combined with limited time for detailed discussions
with participants, undermine participants’ understanding in all countries (Flory & Emanuel,
2004), but perhaps even more so in settings like Malawi (Karim, 1998).
The most striking difference between reviews by this REC and by RECs in developed
countries is the priority given to evaluating research in terms of community benefits. This
may reflect the communal nature of society; and it may also reflect concern about economic
and scientific exploitation that has determined the worldview of many in Africa. Research is
judged on standards of “fair benefits,” including benefits to participants and populations
both during and after research (Participants in the 2001 Conference on Ethical Aspects of
Research in Developing Countries, 2004). These standards are different from those used in
the U.S. (Churchill et al., 2003), although a number of international research ethics codes
and guidelines have been revised to accommodate demands for social justice in research
(CIOMS, 2002).
A corollary to the focus on societal benefit is the different attitude expressed by REC
members regarding voluntary and autonomous decision-making. A number of authors have
written about the limitations on individual autonomy in Africa, and the potential
consequences for subjects’ voluntariness (Ijsselmuiden & Faden, 1992; Kasenene, 1994;
Dawson & Kass, 2005), although the relative balance of consent (communal, family, and
individual) needed in traditional societies is still uncertain (Bhutta, 2004).
Best Practices
Despite limited generalizability, many observations and concerns raised in our interviews
resonate with reports from other countries where RECs face similar role tensions (Amdur &
Banker, 2005), and increasing pressures and conflicts in competitive, commercialised
research environments (Hunter, 2005; Nelson, 2006a; Nelson, 2006b; Campbell et al.,
2006). In light of such pressures, some have suggested strengthening local and regional
regulatory frameworks and legislation (Chima, S.C., 2007).
To improve the consent process, REC members recommended that investigators spend more
time explaining the study to potential study participants. This approach has been described
in a review of interventions (Agre et al., 2003) as possibly the most effective method to
improve participants’ understanding of informed consent. Furthermore, consent forms must
be shorter and the meanings of the concepts must be maintained after translation into the
local language. A few interventions in resource-poor countries have been successful,
including dividing the consent process over several sessions (Fitzgerald, Marotte, Verdier,
Johnson, & Pape, 2002) and using a context-specific informed consent approach that
includes local explanations and analogies (Corneli et al., 2007; Corneli, 2003). A conceptual
framework for improving participants’ understanding has also been proposed (Woodsong &
Karim, 2005). The need to assure subjects’ informed consent is even more urgent in light of
the finding that REC members consider stigmatization from association with an HIV/AIDS
trial to be so pervasive (Goldin, 1994).
International investigators who plan to conduct research in sub-Saharan Africa—and the
RECs at their home institutions—should be aware of the values of community benefit and
relational autonomy that are part of this REC’s framework of human subjects review. They
should also be aware of the potentially critical flaws in their consent forms and processes
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that seriously undermine participants’ understanding. Changes can and should be made to
improve these aspects of international research.
Research Agenda
As identified here, an important next step is to determine mechanisms to improve
communications and understanding between RECs in the U.S., U.K., and Europe, and those
in developing countries. Additional qualitative research can be carried out with several
RECs to determine the best mechanisms to accomplish these goals. Suggested mechanisms
identified through such research for improving communication could then be put into
practice during a trial period with paired RECs, followed by a formal evaluation to
determine effective communication strategies.
Educational Implications
Often the best educational approach is bi-directional exchange. Members of RECs from the
West should visit members from developing country RECs to observe their meetings, and
gain a better understanding of the local research environment by visiting research facilities
and communities. Likewise, members of RECs from developing countries should visit those
in the U.S., U.K., or Europe, to become more familiar with how RECs in the West review
protocols. Of note, to follow-up the research described here, an author on this manuscript
travelled to Malawi and observed an REC meeting, reviewed various local guidelines and
operating procedures, informally discussed with REC members their perceived training
needs, and together with the Chair of the REC made recommendations for the next steps
pertaining to training/continuing education. The Chair of the Malawi REC and a member of
the National Research Council then traveled to the U.S., and spent a week observing several
RECs in North Carolina and had discussions with University faculty and REC personnel. In
addition, three authors on this manuscript provided a three-day ethics training in Malawi for
this REC as well as the other Malawi REC. These ongoing interactions have built a level of
trust and mutual respect that now support a cooperative review arrangement between the
national Malawi REC and our university-based REC in the U.S., providing for reliance on
one REC for some aspects of review and reducing duplication of effort. This type of
collaboration is increasingly encouraged among U.S. RECs., and is a positive reflection of
capacity building and bi-directional education.
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